GW Pharmaceuticals PLC (GWPH - Free Report) closed the most recent trading day at $145.71, moving -1.05% from the previous trading session. This move lagged the S&P 500's daily loss of 0.63%. At the same time, the Dow lost 0.43%, and the tech-heavy Nasdaq lost 1.04%.
Heading into today, shares of the company had lost 6.18% over the past month, trading in line with the Medical sector and outpacing the S&P 500's loss of 6.28% in that time.
GWPH will be looking to display strength as it nears its next earnings release, which is expected to be December 3, 2018. On that day, GWPH is projected to report earnings of -$2.39 per share, which would represent a year-over-year decline of 9.63%. Our most recent consensus estimate is calling for quarterly revenue of $3.61 million, up 26.05% from the year-ago period.
Investors should also note any recent changes to analyst estimates for GWPH. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 2.42% higher within the past month. GWPH currently has a Zacks Rank of #2 (Buy).
The Medical - Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 96, putting it in the top 38% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.